The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
39
No.
27
July 03, 2013
TCL
Vol.
39
No.
29
July 19, 2013
- A “Screw-Up” Worked in MD Anderson’s Favor In Seven-Year Stint as U.S. News & World Report Top-Ranked Cancer Center
- Correcting the Error: What U.S. News Could and Couldn’t Do to Fix the Problem
- BSA Approves Six Concepts
- Zwelling Moves to Legacy Community Health
- Greenberg Named UT System Vice Chancellor For Health Affairs
TCL
Vol.
39
No.
30
July 25, 2013
- Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement
- Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center
- R01 and P01 Grants Will No Longer Support Phase III Clinical Trials
- House Committee Seeks Review Of Indirect Costs Of NIH Grantees
- Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin
CCL
Vol.
36
No.
7
July 26, 2013
- GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL
- Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy
- FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug
- Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden
- ASCO Recommends Discussing Pharmacological Prevention
- Elderly and Younger Patients Have Similar Outcomes Following Radioembolization
- Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness
- Statistical Models Determine Stem-Cell Transplant Effectiveness
- Phase II Elotuzumab Study Demonstrates 33 Months PFS
- Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study
- Biomarker Test Outperforms PSA and Gleason Score in Study
- NCI CTEP Approved Trials For the Month of July
- FDA Approves Implant For Breast Reconstruction
TCL
Vol.
39
No.
32
August 09, 2013
- Northwestern Repays Government $3 Million To Settle Claims Over Use Of NCI Grants; Researcher Bennett Now Faces Feds Alone
- What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade
- GAO Report Finds Increase in Self-Referred Pathology Services
- National Lung Cancer Partnership Announces Annual Grant Competition
- Wender Named ACS Chief Cancer Control Officer
- Long-time NCI Spokesman Paul Van Nevel Dies at 75
CCL
Vol.
36
No.
8
August 30, 2013
- GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile
- Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease
- Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer
- CMX001 Reduces Adenovirus Progression and Viremia
- Biomarker Identified Predicting Graft-Versus-Host Disease Risk
- Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan
- Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival
- Pretreatment with Azacitidine Achieves 28-Month Remission
- Specific Pathology Pattern Can Predict Recurrence
- 20% of Women Do Not Believe Tailored Risk Assessments
- Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer
- Study Finds Gene Expression Test Predicts Stage I or II Recurrence
- NCI CTEP Approved Trials For the Month of August
- FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma
